Oncology & Cancer

Men say they want prostate cancer test, despite risks

A survey of men age 40 to 74 found that 54 percent said that they would still opt for a popular prostate cancer screening test despite recent recommendations that the test not be performed, finds a new study in American Journal ...

Oncology & Cancer

Predicting prostate cancer recurrence 15 months sooner

A Purdue University mechanical engineer and his international collaborators have developed a patent-pending method and algorithm to predict the recurrence of prostate cancer in patients treated by radiation therapy.

Oncology & Cancer

How microchips could help detect prostate cancer

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer.

page 24 from 33